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Abstract
Background: Rhegmatogenous retinal detachment (RRD) is a potentially blinding condition and a
common cause of ocular morbidity. Establishing an accurate estimate of disease incidence and
distribution is an important first step in assessing the healthcare burden related to this condition
and in subsequent planning and provision of treatment strategies. The aim of this study is to obtain
a first estimate incidence of RRD in Scotland, to estimate the incidence of familial RRD and to
describe the known associations of RRD within the study population.
Methods/Design: We have established a national prospective observational study seeking to
identify and recruit all incident cases of RRD in the Scottish population over a 2 year period. After
fully informed consent, all participants will have a blood sample taken and a full medical history and
clinical examination performed including visual acuity, refraction, slit-lamp examination, intra-ocular
pressure measurement and detailed fundal examination. We describe the study design and
protocol.
Conclusion: This study will provide the first estimate of the annual incidence of RRD in Scotland.
The findings of this study will be important in estimating the burden of disease and in the planning
of future health care policy related to this condition. This study will also establish a genetic resource
for a genome wide association study to investigate if certain genetic variants predispose to RRD.
Background
Rhegmatogenous retinal detachment (RRD) is a poten-
tially blinding ophthalmic pathology caused by a separa-
tion of the neurosensory retina (NSR) from the
underlying retinal pigment epithelium and the accumula-
tion of fluid within this potential space. It is responsible
for up to 2% of blind and partial sight registrations in Ire-
land, Scotland and south west England [1-3]. The main-
stay of RRD treatment is surgical, accounting for an
important proportion of ophthalmic hospital in-patient
admissions at an annual cost of over £1.3 million in the
U.K [4]. The principles defining an epidemiology study
are the careful delineation of the study population from
which cases are derived and the effort to ascertain every
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eligible case from the study population [5]. To date there
have been no large-scale systematic epidemiology studies
of RRD in Scotland. Previous population based estimates
of the incidence of RRD have varied considerably, with
overall annual incidence rates reported between 5–17.9
per 100,000 of population [6-16]. Based on these previ-
ous reports, we estimate that there are between 500–600
new cases of RRD in Scotland annually.
The genetic risk of RRD has been investigated through
family linkage studies[17,18] and twin reports [19-21]. It
has also been noted that familial occurrence of RRD is a
risk factor for its' development, with a risk ratio of 2.6 for
cumulative lifetime risk of RRD in relatives of subjects
with RRD compared to relatives of those without
RRD[22]. Recently, genome-wide association (GWAS)
studies have become established as powerful tools in
identifying common genetic variants that predispose to
common, complex disease. These case-control studies
seek to characterize DNA nucleotide polymorphisms in a
large number of cases and disease-free controls to deter-
mine if certain polymorphisms are associated with the
disease phenotype[23]. To date no GWAS have been con-
ducted on rhegmatogenous retinal detachment. Our study
will establish an important resource for further explora-




To establish a complete case register of new cases of RRD
in the Scottish population over a 2 year period
To calculate the incidence of RRD in the Scottish popula-
tion.
To determine the incidence of familial rhegmatogenous
retinal detachment in Scotland.
To examine the prevalence of myopia, trauma, peripheral
retinal degeneration and previous intra-ocular surgery
within the study sample
Secondary
To provide data to inform the planning of vitreoretinal
surgical services in Scotland
To define abnormalities present in the second eye of
patients presenting with rhegmatogenous retinal detach-
ment.
2 – Genome – Wide Association
To utilise the Scottish rhegmatogenous retinal detach-
ment study database in a case-control analysis to identify
common genetic variants predisposing to rhegmatoge-
nous retinal detachment.
To conduct a genome-wide association study of RRD to
identify novel common genetic variants associated with
risk of RRD.
To verify the contribution of these genetic loci in a repli-
cation study in collaboration with other well-character-
ised RRD case-control collections.
Methods/Design
Scottish Population
This study is a prospective population-based epidemiol-
ogy study in Scotland. The study participants are derived
from the entire resident population of Scotland. The last
formal census was conducted in April 2001 and was
administered over one day. Data was gathered on all usual
residents (excluding visitors) in Scotland. It was a highly
accurate census with an overall response rate of 96% and
an estimated coverage of 100%. The usual resident popu-
lation of Scotland in 2001 was 5.062 million people.
Fourteen health boards are established in Scotland to
administer the Scottish health service. These health
boards are divided geographically (See Figure 1) and all
diagnosed RRD cases in Scotland are referred to one of six
vitreo-retinal surgical sites for assessment and surgery. The
established structure of the Scottish health service and the
organisation of the ophthalmology community in Scot-
land will permit high levels of co-operation and case
ascertainment. Figure 2 highlights the health board distri-
bution and age structure of the Scottish population.
Participating centres and protocol
The six vireo-retinal surgical sites (Ayr, Glasgow, Edin-
burgh, Dundee, Aberdeen and Inverness) are geographi-
cally distributed across different health boards and they
are responsible for and manage the operative workload of
cases requiring retinal surgery throughout Scotland. Thus,
each identified case will be referred to one of these centres
for assessment and further management. There are 16 vit-
reo-retinal consultant specialists in Scotland who are
actively participating in this study.
Sample Size
Based on previous estimates of RRD incidence and current
population data, we hypothesise that there are approxi-
mately 500–600 new cases of RRD in Scotland annually.
A collection period of 2 years with a predicted recruitment
rate of 90% will provide a feasible collection period and
an appropriate sample size to estimate disease incidence
with a 95% confidence interval of less than 3 cases annu-
ally per 100,000 of population. (based on Poisson distri-
bution) Moreover, a sample size of 1,000 Scottish cases inBMC Ophthalmology 2009, 9:2 http://www.biomedcentral.com/1471-2415/9/2
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Health board distribution in Scotland Figure 1
Health board distribution in Scotland. (Courtesy of the National Registry Office, Scotland).BMC Ophthalmology 2009, 9:2 http://www.biomedcentral.com/1471-2415/9/2
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conjunction with a further 1,000 cases recruited from else-
where in the UK and Europe will provide the genetic
resource for a 2-stage genome wide association study with
acceptable power to detect a genotypic risk ratio of
approximately 1.5 at a minor allele frequency of 10–15%
or greater. Figure 3 illustrates a number of power calcula-
tions for several of different sample sizes with an esti-
mated disease prevalence of 0.003[9] using a case-control
power calculator for a two stage association study: http://
www.sph.umich.edu/csg/abecasis/CaTS/
Case identification and recruitment
All incident cases of rhegmatogenous retinal detachment
presenting to all participating centres are invited for inclu-
sion into the study. The diagnosis of RRD is based on a
case definition of "a full thickness break in the neurosen-
sory retina with a surrounding area of sub-retinal fluid
extending greater than 2 disc diameters" [7,8,14,24]. No
distinction is made in this study between clinical and sub-
clinical retinal detachment, all diagnosed cases are
invited[24]. As the original definition shows observer
dependant bias, we extended RRD classification in surgi-
cal terms as any break in the neurosensory retina with sur-
rounding sub-retinal fluid requiring intervention more
than cryotherapy and/or laser treatment to reattach or sta-
bilise the retina. Thus in practice any patient who has a
RRD of significant size which is treated with barrier laser
alone as well as those who undergo an operative proce-
dure including vitrectomy and internal tamponade, pneu-
moretinopexy or external buckle are included. Patients are
also included if they present with a RRD but for medical,
social or occupational reasons the decision to perform
surgery was not taken. Blunt traumatic cases of RRD are
included, penetrating trauma is excluded. All other types
of retinal detachment (exudative, tractional and com-
bined) are excluded. Re-detachments regardless of dura-
tion of attachment post-operatively are excluded.
Data Quality
A number of procedures were established to ensure opti-
mal data quality. Firstly, each centre was visited and didac-
tic tutorials were established with the retinal department
staff and nominated local investigators. All nominated
investigators were trained by demonstration and explana-
tory protocols on accurate completion of the question-
naires. Each site is visited regularly to guarantee data
completeness. The busier centres are visited between one
to three times weekly, and the outlying centres are visited
more infrequently, approximately every 2–3 weeks. The
principal investigator liaises with all nominated investiga-
tors in these outlying sites on a weekly basis. All incident
cases are identified and approached for inclusion while in
hospital.
Participant Consent and Data Fields Recorded
Cases eligible for recruitment are confirmed through clin-
ical examination by a retinal consultant. Detailed history
and examination is performed on all cases by the princi-
pal investigator or by an appointed local investigator.
Blood sampling is performed on all consenting partici-
pants. Individual informed consent is received on the
basis that each participant understands and has time to
consider the merits of study participation; participation is
voluntary and does not affect subsequent care of the
patient; the DNA sample and clinical data about the indi-
vidual would be stored by the research team at Edinburgh
The age and population structure of all Scottish residents in each health board region in the 2001 population census Figure 2
The age and population structure of all Scottish residents in each health board region in the 2001 population 
census. (Courtesy of the National Regsitry Office, Scotland) Note- Argyll and Clyde is now considered part of the Highland 
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University for use in future research and may be shared
with other medical research groups (with appropriate eth-
ical approvals first being obtained where necessary). Data
fields gathered comprise:
1. Ocular parameters
History of trauma and type of trauma; refractive status
(prior to cataract or retinal surgery); previous ophthalmic
history; including date of any previous ophthalmic sur-
gery or laser treatment; nature and duration of symptoms;
route of referral; type of retinal detachment at presenta-
tion; vitreous – attached/detached, syneresis, features of
Sticklers/Wagners syndrome or other hereditary vitreo-
retinopathy; peripheral retina – Presence and subtype of
any peripheral retinal degeneration; second eye – docu-
mentation of any vitreo-retinal pathology.
2. Personal, family history, demographic, treatment
Ethnicity; parental consanguinity; family history of eye
disease; family history of retinal detachment. A positive
family history is considered to be any first degree relative
affected by a retinal detachment which required treat-
ment. (i.e. subclinical cases which did not warrant treat-
ment were not considered) Demographic data is taken
direct from patients and NHS clinical notes. Type and date
of surgery procedure is noted.
Data Validation
Several validation techniques have been established to
ensure complete case capture. Firstly, surgical logbooks in
each centre (where each operation is recorded in detail)
are examined on a regular basis to determine all cases that
underwent vitreo-retinal surgery of any type. This list is
then cross referenced with collected data during this time
period to identify any potentially missed cases. Subse-
quently, all out-patient and discharge letters are viewed to
determine how many cases were not recruited during the
short time period.(e.g. one week) Any ambiguous or
incomplete information is followed up by examination of
individual clinical case-notes or by contacting the patient
or surgeon directly. Cases that were missed in hospital are
invited for inclusion at the first follow up appointment.
Each nominated local investigator is also asked to record
information on any willing participant who did not
undergo surgery for medical or other reasons. Through
these rigorous techniques we are confident in achieving a
high case ascertainment level.
Assessing under-ascertainment
Using a capture-recapture methodology, we will estimate
the level of under-ascertainment in our study in order to
obtain more accurate approximation of disease incidence.
Capture-recapture methodology aims to adjust for the
extent of incomplete ascertainment using information
from overlapping lists of cases from distinct sources[25].
The information services division (ISD) has been estab-
lished for over 40 years in Scotland and is a national
organisation for health information and statistics. It com-
prises detailed data on all hospital and out-patient activity
on a monthly basis across Scotland. All diagnostic and
discharge data in Scotland is recorded and classified
according to the International Classification of Disease
(ICD) criteria. This data is accessible through an oversight
committee and is part of NHS National Services Scotland.
By comparing this data with data generated by our study
we will conduct a two-source capture-recapture study to
calculate the maximum likelihood estimate of ascertain-
ment between the databases and provide a more accurate
estimation of true disease incidence.
Statistical analysis
We will calculate standard error estimates and the 95% con-
fidence intervals for all categorical and continuous data.
Annual age and sex standardised incidence rates will be cal-
culated. The prevalence rate and association of refractive
error, peripheral retinal degeneration, and previous intra-
ocular surgery with RRD in our study population will be
calculated and presented. The analysis of the genome wide
association study will be based on one-locus association
tests with two degrees of freedom in order to avoid assump-
tions about the locus genetic model.
Examination protocol
Visual acuity
Visual acuity at presentation is performed by a trained
nurse practitioner using a Snellen chart at 6 meters. Best
corrected visual acuity is measured separately for each eye
and is recorded as the smallest line which the patient can
correctly read. If the largest letter is not visualised (6/60),
Power estimates by genotypic relative risk (GRR) and allele  frequency for a 2 stage genome wide association study with a  total sample size of 2000 cases and controls Figure 3
Power estimates by genotypic relative risk (GRR) 
and allele frequency for a 2 stage genome wide asso-
ciation study with a total sample size of 2000 cases 
and controls.BMC Ophthalmology 2009, 9:2 http://www.biomedcentral.com/1471-2415/9/2
Page 6 of 7
(page number not for citation purposes)
the examiner tests finger counting at one meter. The exam-
iner will then test 'hand motion' detection at one meter
and finally light perception is tested by with a pen-torch
light and a visual acuity of perception of light, or no per-
ception of light is then recorded. Focimetry is also per-
formed on all participants who wear glasses.
Slit lamp examination
A slit lamp examination is performed on all participants.
After appropriate positioning of the patient, the anterior
segment of each eye is examined and the structures of the
anterior segment are inspected for any lesions or abnor-
malities which are then documented.
Applanation tonometry
Intra-ocular pressure is measured by a standard method
using a Goldmann Applanation Tonometer.
Dilated fundal examination
All participants have both eyes dilated and a systematic
examination of both fundi is performed by a consultant
ophthalmologist. Examination is performed initially at
the slit-lamp using a condensing lens and subsequently
using the indirect ophthalmoscope with scleral indenta-
tion. Each quadrant is examined thoroughly and all noted
pathology is recorded on a standardised fundal drawing.
Definitions
Type of RRD
Three conditions must be satisfied to cause RRD: vitreous
liquefaction, tractional forces producing a retinal break
and an open retinal break allowing fluid to gain access to
the sub-retinal space.[26] The subtype of RRD is described
according to the type of retinal break causing the detach-
ment and may be classified as follows:
Horse-shoe shaped tear
This refers to tear in the neurosensory retina (NSR) due to
a persistent site of vitreo-retinal traction during a posterior
vitreous detachment.
Giant Retinal Tear
These are defined as circumferential retinal breaks of 90
degrees or more. The tear is usually along the posterior
margin of the vitreous base, may have a rolled edge and
rarely may occur at the anterior margin in the ciliary epi-
thelium [27].
Dialysis
Defined as circumferential tears along the ora serrata with
persistent vitreous attachment to the posterior retina (ie.
No posterior vitreous detachment) [28].
Round Hole
This refers to an avulsed or operculated area of peripheral
retina induced by a complete or localised vitreous separa-
tion. It may also refer to atrophic retinal holes associated
with areas of pigmentation or peripheral retinal degener-
ation.
Retinoschisis
This describes a degenerative process causing a splitting of
the retinal layers. If retinal breaks occurs in both the outer
and inner leaves of a retinoschisis causing a progressive
extension of sub-retinal fluid requiring intervention this is
classified as a retinoschisis detachment [29].
Ocular features defined
A myopic refractive error is defined as a spherical equiva-
lent refractive error of<-1 dioptre (D), a hypermettropic
refractive error as a spherical equivalent refractive error of
>+1 D and emmetropia as a spherical equivalent refractive
error of between -1 and +1 D.
Trauma is defined as any direct or indirect trauma to the
eye resulting in loss or disturbance of vision warranting
ophthalmological review.
Posterior vitreous detachment is due to progressive lique-
faction of the aging vitreous which induces its separation
from the inner-limiting membrane of the retina. This
process may be partial or complete (often seen as a Weiss
ring with no detectable adhesions around the posterior
pole).[30]
Peripheral retinal degeneration delineates peripheral reti-
nal lesions which cause anomalies in vitreo-retinal adhe-
sion which may predispose to RRD.
Lattice degeneration is characterised clinically as circum-
ferentially distributed, sharply demarcated, elliptical areas
of peripheral retinal thinning with variable pigmentation.
There are often localised areas of overlying vitreous lique-
faction, a criss-crossing network of hyalinised vessels and
exaggerated vitreoretinal attachments along the edge of
the lesion [31].
Ethical aspects
Multi-centre research ethics committee (Scotland)
approval and NHS Trust management committee
approval have been obtained from all participating sites.
All participants included in the study are fully informed
about the study. Participation is voluntary, individuals
may withdraw at any stage and participation does not
affect the treatment of the individual. All data is recorded
and stored in compliance with ethical and data protection
guidelines.
Discussion
This study describes a prospective population based
observational design which aims to accurately character-
ise the incidence and clinical associations of RRD in a wellPublish with BioMed Central    and   every 
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defined population. Findings from this study will repre-
sent a first estimate incidence of RRD in Scotland and will
highlight the healthcare burden and distribution of this
potentially blinding condition. This study will also pro-
vide an important genetic resource for the investigation of
the genetic contribution to the aetiology of this condition.
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